Stopped: The study was withdrawned because of lack of relevant devices in the study center
This prospective observational validation study aims to evaluate the agreement and diagnostic accuracy of ClearSightâ„¢ compared with transthoracic echocardiography (TTE) during PLR in term pregnant women. The ultimate goal is to determine whether ClearSightâ„¢ can reliably identify preload responsiveness in term pregnant women compared with the echocardiographic gold standard. The clinical implication is that, if validated, ClearSightâ„¢ may reduce unnecessary or harmful fluid administration by accurately detecting preload reserve, and improve maternal safety in peripartum care by providing obstetric anesthesiologists with reliable bedside monitoring tools.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Agreement between ClearSightâ„¢-derived stroke volume index (SVI) changes and TTE-derived Left Ventricular Outflow Tract - Velocity Time Integral (LVOT-VTI) changes during PLR.
Timeframe: During PLR